AzTrials
AzTrials

HysterectomyNCT07445880

Clinical Application and Efficacy of a Self-Locking Uterine Manipulator Stand in Hysterectomy

A study testing a Universal Self-Locking Uterine Manipulator Stand in people with Hysterectomy, run by Women's Hospital School Of Medicine Zhejiang University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary goal of this clinical trial is to evaluate whether a Universal Self-Locking Uterine Manipulator Stand can reduce the level of fatigue experienced by clinicians during total hysterectomy.The key question it aims to answer is: Can the Universal Self-Locking Uterine Manipulator Stand reduce surgeon fatigue… Read more about this study

Who is it for?
Ages 18 to 75 years, women only
Conditions the study is for
Hysterectomy
What is being tested?
a Universal Self-Locking Uterine Manipulator Stand
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteChina
Study dates
1 May 2023to 12 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Medical Staff:
  • Possess a national medical license (doctors) or registered nurse qualification (nurses)
  • Doctors: have obtained corresponding surgical qualifications through the hospital's endoscopic surgery grading system
  • Nurses: have at least 5 years of operating room experience at the study hospital
  • All surgical procedures are performed by a consistent surgical team
  • Surgical Patients:
Show all 10Show fewer
  • Age 18 to 75 years
  • Undergoing tracheal intubation general anesthesia
  • No contraindications for uterine manipulation
  • Willing to participate voluntarily and provide written informed consent

Who cannot join

  • Preoperative B-ultrasound indicating uterine size ≥ 4 months
  • Cervical treatment surgery within the past 3 months
  • Failed placement of the uterine support device
  • Need for intraoperative conversion to a different surgical method
  • Need for intraoperative removal of the auxiliary uterine support device due to special circumstances

Trial locations and contacts

1 site in 1 country.

China1 site
  • Women's Hospital School Of Medicine Zhejiang University

    Hangzhou, Zhejiang, 310000

Other trials in China

About this study

Official title: Effectiveness of a Universal Self-Locking Uterine Manipulator Stand in Hysterectomy:a Single-center,Single-blind, Randomized Controlled Study

The primary goal of this clinical trial is to evaluate whether a Universal Self-Locking Uterine Manipulator Stand can reduce the level of fatigue experienced by clinicians during total hysterectomy.The key question it aims to answer is:

  • Can the Universal Self-Locking Uterine Manipulator Stand reduce surgeon fatigue during intraoperative uterine manipulation? Participants will be randomly assigned to either the experimental group or the control group. In the experimental group, the Universal Self-Locking Uterine Manipulator Stand will be utilized during surgery, whereas in the control group, an assistant surgeon will perform uterine manipulation manually using a standard uterine manipulator.
Conditions
Hysterectomy
Being tested
a Universal Self-Locking Uterine Manipulator Stand
Keywords
Laparoscopic hysterectomy, Uterine manipulator

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • a Universal Self-Locking Uterine Manipulator StandDevice

    To perform uterine manipulation with a Universal Self-Locking Uterine Manipulator Stand during total hysterectomy.

Study groups in NCT07445880
Study groupRoleWhat they receive
Universal self-locking uterine manipulator standExperimentalThe intervention in the experimental group included: ① Preoperative training for doctors and nurses. Through hands-on demonstrations and video explanations, the structure, function, usage methods, and precautions of the Wanxiang Stop auxiliary uterine lifting support were introduced. ② During the operation, the surgeon used the Wanxiang Stop auxiliary uterine lifting support throughout the process for uterine lifting operations. And according to the surgical requirements, adjustments were made and the surgical field was exposed.
Receives: Device: a Universal Self-Locking Uterine Manipulator Stand
Manual uterine manipulationNo interventionThe control group underwent the procedure with the surgical assistant using traditional manual uterine lifting techniques throughout. The surgical field was adjusted and exposed according to the surgical requirements.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative Fatigue

    Fatigue was assessed using the Borg Rating of Perceived Exertion (RPE) scale, a 6-to-20 point subjective scale. A score of 6 indicates no exertion and 20 indicates maximal exertion. Higher scores represent greater perceived physical fatigue.

    Measured: At the end of surgery, prior to transfer to the recovery room.

Secondary outcomes (6)
  1. Surgeon Satisfaction with Surgical Field Exposure

    Surgeon satisfaction was assessed using a self-developed 5-point Likert scale. The scale evaluated the clarity of the surgical field exposure, with response options ranging from "very unsatisfied" to "very satisfied". Scores range from 1 to 5, with higher scores indicating greater satisfaction.

    Measured: Within 30 minutes post-surgery

  2. Intraoperative Blood Loss

    Blood loss during surgery, measured in milliliters (mL).

    Measured: Intraoperatively

  3. Intraoperative Leg Abduction Angle

    The maximum angle of leg abduction during surgery, measured in degrees.

    Measured: Intraoperatively

  4. Total Surgery Duration

    Time from skin incision to wound closure, measured in minutes.

    Measured: Intraoperatively

  5. Vaginal Wall Rotation and Resection Time

    Time required for vaginal wall rotation and resection, measured in minutes.

    Measured: Intraoperatively

  6. Incidence of Adverse Events

    Any intraoperative or postoperative adverse events.

    Measured: Intraoperative and up to 30 days post-surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2026
  2. Study start1 May 2023
  3. Primary completion12 Dec 2023
  4. Study completion12 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07445880
Sponsor's protocol ID
IRB-20230141-R
Status last verified
Feb 2026
First submitted
25 Jan 2026
Last updated
3 Mar 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing a Universal Self-Locking Uterine Manipulator Stand in people with Hysterectomy, run by Women's Hospital School Of Medicine Zhejiang University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative Fatigue (time frame: At the end of surgery, prior to transfer to the recovery room.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in